this thing is capped at $4.5m with significant success in their first batch of treated patients. Its been a long time since i have seen a small bio stock have success with human trials. Have a read of the announcement if you like, it might be a very interesting ride over time for a company like this. The first 10 patients all scored 100%. dyor.
majo milestone for human trials.capped at zip.
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable